Human genetic deficits in glycan formation

Proceedings of the Japan Academy Series B: Physical and Biological Sciences

Volumn 80, Issue 3, 2004, Pages 128-139

  Endo, Tamao ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Congenital disorder of glycosylation; Glycosyltransferase; Muscular dystrophy; N glycosylation; O mannosylation

Indexed keywords

MAMMALIA;

EID: 2542522462     PISSN: 03862208     EISSN: None     Source Type: Journal    
DOI: 10.2183/pjab.80.128     Document Type: Review

References (67)

1. Varki, A. (1993) Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3, 97-130.
2. Bruckner, K., Perez, L., Clausen, H., and Cohen, S. (2000) Glycosyltransferase activity of Fringe modulates Notch-Delta interactions. Nature 406, 411-415.
3. Moloney, D. J., Panin, V. M., Johnston, S. H., Chen, J., Shao, L., Wilson, R., Wang, Y., Stanley, P., Irvine, K. D., Haltiwanger, R. S. et al. (2000) Fringe is a glycosyltransferase that modifies Notch. Nature 406, 369-375.
4. Okajima, T., and Irvine, K. D. (2002) Regulation of Notch signaling by O-linked fucose. Cell 111, 893-904.
5. Shi, S., and Stanley, P. (2003) Protein O-fucosyltransferase 1 is an essential component of Notch signaling pathways. Proc. Natl. Acad. Sci. USA 100, 5234-5239.
6. Lowe, J. B., and Marth, J. D. (2003) A genetic approach to mammalian glycan function. Annu. Rev. Biochem. 72, 643-691.
7. Endo, T. (1999) O-Mannosyl glycans in mammals. Biochim. Biophys. Acta 1473, 237-246.
8. Freeze, H. H. (2002) Human disorders in N-glycosylation and animal models. Biochim. Biophys. Acta 1573, 388-393.
9. 2-PP-dolichyl α3-glucosyltransferase defines a new subtype of congenital disorders of glycosylation. J. Biol. Chem. 278, 9962-9971.
10. Thiel, C., Schwarz, M., Peng, J., Grzmil, M., Hasilik, M., Braulke, T., Kohlschutter, A., von Figura, K., Lehle, L., and Korner, C. (2003) A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis. J. Biol. Chem. 278, 22498-22505.
11. Wu, X., Rush, J. S., Karaoglu, D., Krasnewich, D., Lubinsky, M. S., Waechter, C. J., Gilmore, R., and Freeze, H. H. (2003) Deficiency of UDP-GlcNAc: dolichol phosphate N-acetylglucosamine-1 phosphate transferase (DPAGT1) causes a novel congenital disorder of glycosylation type Ij. Hum. Mutat. 22, 144-150.
12. Tan, J., Dunn, J., Jaeken, J., and Schachter, H. (1996) Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development. Am. J. Hum. Genet. 59, 810-817.
13. Lubke, T., Marquardt, T., Etzioni, A., Hartmann, E., von Figura, K., and Korner, C. (2001) Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat. Genet. 28, 73-76.
14. Luhn, K., Wild, M. K., Eckhardt, M., Gerardy-Schahn, R., and Vestweber, D. (2001) The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter. Nat. Genet. 28, 69-72.
15. Hansske, B., Thiel, C., Lubke, T., Hasilik, M., Honing, S., Peters, V., Heidemann, P. H., Hoffmann, G. F., Berger, E. G., von Figura, K. et al. (2002) Deficiency of UDP-galactose: N-acetylglucosamine β-1,4- galactosyltransferase I causes the congenital disorder of glycosylation type IId. J. Clin. Invest. 109, 725-733.
16. Strahl-Bolsinger, S., Gentzsch, M., and Tanner, W. (1999) Protein O-mannosylation. Biochim. Biophys. Acta 1426, 297-307.
17. Timpel, C., Strahl-Bolsinger, S., Ziegelbauer, K., and Ernst, J. F. (1998) Multiple functions of Pmt1p-mediated protein O-mannosylation in the fungal pathogen Candida albicans. J. Biol. Chem. 273, 20837-20846.
18. Spiro, R. G., and Bhoyroo, V. D. (1980) Studies on the carbohydrate of collagens. Characterization of a glucuronic acid-mannose disaccharide unit from Nereis cuticle collagen. J. Biol. Chem. 255, 5347-5354.
19. Krusius, T., Reinhold, V. N., Margolis, R. K., and Margolis, R. U. (1987) Structural studies on sialylated and sulphated O-glycosidic mannose-linked oligosaccharides in the chondroitin sulphate proteoglycan of brain. Biochem. J. 245, 229-234.
20. Krusius, T., Finne, J., Margolis, R. K., and Margolis, R. U. (1986) Identification of an O-glycosidic mannose-linked sialylated tetrasaccharide and keratan sulfate oligosaccharides in the chondroitin sulfate proteoglycan of brain. J. Biol. Chem. 261, 8237-8242.
21. Finne, J., Krusius, T., Margolis, R. K., and Margolis, R. U. (1979) Novel mannitol-containing oligosaccharides obtained by mild alkaline borohydride treatment of a chondroitin sulfate proteoglycan from brain. J. Biol. Chem. 254, 10295-10300.
22. Chiba, A., Matsumura, K., Yamada, H., Inazu, T., Shimizu, T., Kusunoki, S., Kanazawa, I., Kobata, A., and Endo, T. (1997) Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve α-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of α-dystroglycan with laminin. J. Biol. Chem. 272, 2156-2162.
23. Sasaki, T., Yamada, H., Matsumura, K., Shimizu, T., Kobata, A., and Endo, T. (1998) Detection of O-mannosyl glycans in rabbit skeletal muscle α-dystroglycan. Biochim. Biophys. Acta 1425, 599-606.
24. Yuen, C. T., Chai, W., Loveless, R. W., Lawson, A. M., Margolis, R. U., and Feizi, T. (1997) Brain contains HNK-1 immunoreactive O-glycans of the sulfoglucuronyl lactosamine series that terminate in 2-linked or 2,6-linked hexose (mannose). J. Biol. Chem. 272, 8924-8931.
25. Chai, W., Yuen, C. T., Kogelberg, H., Carruthers, R. A., Margolis, R. U., Feizi, T., and Lawson, A. M. (1999) High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. Eur. J. Biochem. 263, 879-888.
26. Inamori, K. I., Endo, T., Gu, J., Matsuo, I., Ito, Y., Fujii, S., Iwasaki, H., Narimatsu, H., Miyoshi, E., Honke, K. et al. (2004) N-acetylglucosaminyltransferase IX acts on the GlcNAcβ1,2-Manα1-Ser/ Thr moiety, forming a 2,6-branched structure in brain O-mannosyl glycan. J. Biol. Chem. 279, 2337-2340.
27. Smalheiser, N. R., Haslam, S. M., Sutton-Smith, M., Morris, H. R., and Dell, A. (1998) Structural analysis of sequences O-linked to mannose reveals a novel Lewis X structure in cranin (dystroglycan) purified from sheep brain. J. Biol. Chem. 273, 23698-23703.
28. Wing, D. R., Rademacher, T. W., Schmitz, B., Schachner, M., and Dwek, R. A. (1992) Comparative glycosylation in neural adhesion molecules. Biochem. Soc. Trans. 20, 386-390.
29. Takahashi, S., Sasaki, T., Manya, H., Chiba, Y., Yoshida, A., Mizuno, M., Ishida, H., Ito, F., Inazu, T., Kotani, N. et al. (2001) A new β-1,2-N-acetylglucosaminyltransferase that may play a role in the biosynthesis of mammalian O-mannosyl glycans. Glycobiology 11, 37-45.
30. Yoshida, A., Kobayashi, K., Manya, H., Taniguchi, K., Kano, H., Mizuno, M., Inazu, T., Mitsuhashi, H., Takahashi, S., Takeuchi, M. et al. (2001) Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev. Cell 1, 717-724.
31. Ioffe, E., and Stanley, P. (1994) Mice lacking N- acetylglucosaminyltransferase I activity die at mid-gestation, revealing an essential role for complex or hybrid TV-linked carbohydrates. Proc. Natl. Acad. Sci. USA 91, 728-732.
32. Metzler, M., Gertz, A., Sarkar, M., Schachter, H., Schrader, J. W., and Marth, J. D. (1994) Complex asparagine-linked oligosaccharides are required for morphogenic events during post-implantation development. EMBO J. 13, 2056-2065.
33. Wang, Y., Tan, J., Button-Smith, M., Ditto, D., Panico, M., Campbell, R. M., Varki, N. M., Long, J. M., Jaeken, J., Levinson, S. R. et al. (2001) Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis. Glycobiology 11, 1051-1070.
34. Holt, K. H., Crosbie, R. H., Venzke, D. P., and Campbell, K. P. (2000) Biosynthesis of dystroglycan: processing of a precursor propeptide. FEBS Lett. 468, 79-83.
35. Ibraghimov-Beskrovnaya, O., Ervasti, J. M., Leveille, C. J., Slaughter, C. A., Sernett, S. W., and Campbell, K. P. (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355, 696-702.
36. Winder, S. J. (2001) The complexities of dystroglycan. Trends Biochem. Sci. 26, 118-124.
37. Huang, X., Poy F., Zhang, R., Joachimiak, A., Sudol, M., and Eck, M. J. (2000) Structure of a WW domain containing fragment of dystrophin in complex with β-dystroglycan. Nat. Struct. Biol. 7, 634-638.
38. Burton, E. A., and Davies, K. E. (2002) Muscular dystrophy-reason for optimism? Cell 108, 5-8.
39. Williamson, R. A., Henry, M. D., Daniels, K. J., Hrstka, R. F., Lee, J. C., Sunada, Y., Ibraghimov-Beskrovnaya, O., and Campbell, K. P. (1997) Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dagr1-null mice. Hum. Mol. Genet. 6, 831-841.
40. Cote, P. D., Moukhles, H., Lindenbaum, M., and Carbonetto, S. (1999) Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Nat. Genet. 23, 338-342.
41. Conn, R. D., Henry, M. D., Michele, D. E., Barresi, R., Saito, F., Moore, S. A., Flanagan, J. D., Skwarchuk, M. W., Robbins, M. E., Mendell, J. R. et al. (2002) Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell 110, 639-648.
42. Moore, S. A., Saito, F., Chen, J., Michele, D. E., Henry, M. D., Messing, A., Conn, R. D., Ross-Barta, S. E., Westra, S., Williamson, R. A. et al. (2002) Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 418, 422-425.
43. Saito, F., Moore, S. A., Barresi, R., Henry, M. D., Messing, A., Ross-Barta, S. E., Conn, R. D., Williamson, R. A., Sluka, K. A., Sherman, D. L. et al. (2003) Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron 38, 747-758.
44. Santavuori, P., Somer, H., Sainio, K., Rapola, J., Kruus, S., Nikitin, T., Ketonen, L., and Leisti, J. (1989) Muscle-eye-brain disease (MEB). Brain Dev. 11, 147-153.
45. Taniguchi, K., Kobayashi, K., Saito, K., Yamanouchi, H., Ohnuma, A., Hayashi, Y. K., Manya, H., Jin, D. K., Lee, M., Parano, E. et al. (2003) Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease. Hum. Mol. Genet. 12, 527-534.
46. Manya, H., Sakai, K., Kobayashi, K., Taniguchi, K., Kawakita, M., Toda, T., and Endo, T. (2003) Loss-of-function of an N-acetylglucosaminyltransferase, POMGnT1, in muscle-eye-brain disease. Biochem. Biophys. Res. Commun. 306, 93-97.
47. Kano, H., Kobayashi, K., Herrmann, R., Tachikawa, M., Manya, H., Nishino, I., Nonaka, I., Straub, V., Talim, B., Voit, T. et al. (2002) Deficiency of α-dystroglycan in muscle-eye-brain disease. Biochem. Biophys. Res. Commun. 291, 1283-1286.
48. Dobyns, W. B., Pagon, R. A., Armstrong, D., Curry, C. J., Greenberg, F., Grix, A., Holmes, L. B., Laxova, R., Michels, V. V., Robinow, M. et al. (1989) Diagnostic criteria for Walker-Warburg syndrome. Am. J. Med. Genet. 32, 195-210.
49. Beltrán-Valero de Bernabé, D., Currier, S., Steinbrecher, A., Celli, J., van Beusekom, E., van der Zwaag, B., Kayserili, H., Merlini, L., Chitayat, D., Dobyns, W. B. et al. (2002) Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am. J. Hum. Genet. 71, 1033-1043.
50. Willer, T., Amselgruber, W., Deutzmann, R., and Strahl, S. (2002) Characterization of POMT2, a novel member of the PMT protein O-mannosyltransferase family specifically localized to the acrosome of mammalian spermatids. Glycobiology 12, 771-783.
51. Manya, H., Chiba, A., Yoshida, A., Wang, X., Chiba, Y., Jigami, Y., Margolis, R. U., and Endo, T. (2004) Demonstration of mammalian protein O-mannosyltransferase activity: Coexpression of POMT1 and POMT2 required for enzymatic activity. Proc. Natl. Acad. Sci. USA 101, 500-505.
52. Jurado, L. A., Coloma, A., and Cruces, J. (1999) Identification of a human homolog of the Drosophila rotated abdomen gene (POMT1) encoding a putative protein O-mannosyl-transferase, and assignment to human chromosome 9q34.1. Genomics 58, 171-180.
53. Cormand, B., Pinko, H., Bayes, M., Valanne, L., Santavuori, P., Talim, B., Gershoni-Baruch, R., Ahmad, A., van Bokhoven, H., Brunner, H. G. et al. (2001) Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease. Neurology 56, 1059-1069.
54. Martin-Blanco, E., and Garcia-Bellido, A. (1996) Mutations in the rotated abdomen locus affect muscle development and reveal an intrinsic asymmetry in Drosophila. Proc. Natl. Acad. Sci. USA 93, 6048-6052.
55. Fukuyama, Y., Osawa, M., and Suzuki, H. (1981) Congenital progressive muscular dystrophy of the Fukuyama type - clinical, genetic and pathological considerations. Brain Dev. 3, 1-29.
56. Kobayashi, K., Nakahori, Y., Miyake, M., Matsumura, K., Kondo-Iida, E., Nomura, Y., Segawa, M., Yoshioka, M., Saito, K., Osawa, M. et al. (1998) An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394, 388-392.
57. Aravind, L., and Koonin, E. V. (1999) The fukutin protein family - predicted enzymes modifying cell-surface molecules. Curr. Biol. 9, R836-R837.
58. Hayashi, Y. K., Ogawa, M., Tagawa, K., Noguchi, S., Ishihara, T., Nonaka, I., and Arahata, K. (2001) Selective deficiency of α-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology 57, 115-121.
59. Takeda, S., Kondo, M., Sasaki, J., Kurahashi, H., Kano, H., Arai, K., Misaki, K., Fukui, T., Kobayashi, K., Tachikawa, M. et al. (2003) Fukutin is required for maintenance of muscle integrity, cortical histiogenesis and normal eye development. Hum. Mol. Genet. 12, 1449-1459.
60. Brockington, M., Blake, D. J., Prandini, P., Brown, S. C., Torelli, S., Benson, M. A., Ponting, C. P., Estournet, B., Romero, N. B., Mercuri, E. et al. (2001) Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal glycosylation of α-dystroglycan. Am. J. Hum. Genet. 69, 1198-1209.
61. Brockington, M., Yuva, Y., Prandini, P., Brown, S. C., Torelli, S., Benson, M. A., Herrmann, R., Andersen, L. V., Bashir, R., Burgunder, J. M. et al. (2001) Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 21 as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum. Mol. Genet. 10, 2851-2859.
62. Esapa, C. T., Benson, M. A., Schroder, J. E., Martin-Rendon, E., Brockington, M., Brown, S. C., Muntoni, F., Kroger, S., and Blake, D. J. (2002) Functional requirements for fukutin-related protein in the Golgi apparatus. Hum. Mol. Genet. 11, 3319-3331.
63. Grewal, P. K., Holzfeind, P. J., Bittner, R. E., and Hewitt, J. E. (2001) Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse. Nat. Genet. 28, 151-154.
64. Michele, D. E., Barresi, R., Kanagawa, M., Saito, F., Cohn, R. D., Satz, J. S., Dollar, J., Nishino, I., Kelley, R. I., Somer, H. et al. (2002) Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418, 417-422.
65. Holzfeind, P. J., Grewal, P. K., Reitsamer, H. A., Kechvar, J., Lassmann, H., Hoeger, H., Hewitt, J. E., and Bittner, R. E. (2002) Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Large (myd) mouse defines a natural model for glycosylation-deficient muscle-eye-brain disorders. Hum. Mol. Genet. 11, 2673-2687.
66. Longman, C., Brockington, M., Torelli, S., Jimenez-Mallebrera, C., Kennedy, C., Khalil, N., Feng, L., Saran, R. K., Voit, T., Merlini, L. et al. (2003) Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of α-dystroglycan. Hum. Mol. Genet. 12, 2853-2861.
67. Michele, D. E., and Campbell, K. P. (2003) Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J. Biol. Chem. 278, 15457-15460.